Papers
Research literature with structured metadata.
Trials
Registered studies by status, phase, and compound.
Topics
Indications and themes psychedelics are researched for.
Compounds
Evidence across molecules with rich data.
Countries
Regulation, access, and research activity by region.
Stakeholders
Organizations shaping the space across research, policy, and funding.
People
Investigators, clinicians, and authors with mapped output.
Courses
Training programs and certifications across modalities.
Events
Conferences, workshops, and convenings by date and focus.
Results
Compare outcome data across trials and publications.
Research recaps
Monthly evidence summaries with key takeaways.
Map of research
Landscape view of trials, compounds, and outcomes.
Newsletter
Weekly or daily updates on trials, publications, analysis, and more.
Research Groups
Worldwide map of psychedelic research centres by region.
Road to Access
Science, regulation, and economics on the path to patient access.
Research Network
Interactive co-authorship map of psychedelic researchers.
Top papers
Find needles in the haystack of psychedelic research per topic.
This review (2021) investigates the therapeutic rationale behind the use of psilocybin and MDMA in the treatment of PTSD and depression. Both compounds and the possible treatment modalities (the combination with talk therapy) are discussed. A combination of first MDMA-assisted therapy, followed by psilocybin-assisted therapy is also presented.
This commentary (2018) provides a historical overview of psychedelic research, acknowledging the social, political, and legal controversies that have challenged the field. It argues that despite these hurdles, psychedelic drugs show significant promise for managing a variety of psychiatric disorders.
This review (2018) investigates the models (e.g. medium/high dosage) of psychedelic therapy in both its historical context and possible future directions.
This review paper (2018) presents a theoretical framework that awe is an underlying mechanism that, as a part of the psychedelic experience, promotes ego dissolution (small self, unitive experience).
This review (2018) finds that music may play a larger (active) role in psychedelic therapy and could be responsible for (part of the positive) outcomes.
This review (2018) examines the cellular pathways through which psychedelics act as anti-inflammatory agents by means of selectively blocking the expression of pro-inflammatory mediators and thereby modulating histone modifications and epigenetic signaling. It is thus hypothesized that psychedelics may be of therapeutic value to a wide range of inflammatory disorders in humans.